Aclaris Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. 

CEO
Neal S. Walker
CEONeal S. Walker
Employees
73
Employees73
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
2012
Founded2012
Employees
73
Employees73

ACRS Key Statistics

Market cap
661.31M
Market cap661.31M
Price-Earnings ratio
-9.18
Price-Earnings ratio-9.18
Dividend yield
Dividend yield
Average volume
1.24M
Average volume1.24M
High today
$4.92
High today$4.92
Low today
$4.68
Low today$4.68
Open price
$4.83
Open price$4.83
Volume
373.89K
Volume373.89K
52 Week high
$4.92
52 Week high$4.92
52 Week low
$1.16
52 Week low$1.16

Stock Snapshot

The current Aclaris Therapeutics(ACRS) stock price is $4.74, with a market capitalization of 661.31M. The stock trades at a price-to-earnings (P/E) ratio of -9.18.

On 2026-05-08, Aclaris Therapeutics(ACRS) stock traded between a low of $4.68 and a high of $4.92. Shares are currently priced at $4.74, which is +1.2% above the low and -3.8% below the high.

The Aclaris Therapeutics(ACRS)'s current trading volume is 373.89K, compared to an average daily volume of 1.24M.

In the last year, Aclaris Therapeutics(ACRS) shares hit a 52-week high of $4.92 and a 52-week low of $1.16.

In the last year, Aclaris Therapeutics(ACRS) shares hit a 52-week high of $4.92 and a 52-week low of $1.16.

ACRS News

TipRanks 1d
Aclaris Therapeutics reports Q1 EPS (15c), consensus (16c)

Reports Q1 revenue $2M, consensus $1.32M. “Since the start of 2026, we have made great progress toward our goal of developing best-in-class compounds to address...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.